An 88-year-old woman with a clinical diagnosis of Alzheimer's disease and advanced dementia, was evaluated with standard MRI of the brain as well as Susceptibility Weighted Imaging (SWI) with the MRI. SWI revealed more extensive brain microhemorrhages than standard MRI techniques, allowing the radiologic diagnosis of cerebral amyloid angiopathy. SWI shows promise as a more sensitive diagnostic tool than standard brain MRI for the evaluation of patients with dementia.
Neuroimaging techniques currently used for dementia evaluations are in a state of evolution with continued reassessments and reports of enhanced diagnostic accuracy [1] [2] . Conventional CT and MRI brain imaging detects potentially treatable causes of dementia such as "normal pressure hydrocephalus," chronic subdural hematoma, strokes, and mass lesions [3] . PET scanning and MRI evidence of medial temporal lobe atrophy have been shown to be both sensitive and specific for diagnosing Alzheimer's disease [4] [5] . Gradient-echo T2* (GE-T2*) weighted MR imaging detects cerebral microhemorrhages in lobar and subcortical patterns, findings that are considered highly suggestive for late-onset sporadic cerebral amyloid angiopathy [6] [7] [8] .
Microhemorrhages associated with Alzheimer's disease may be an underestimated cause of progressive cognitive impairment in the elderly [9] . SWI is significantly more sensitive than GE-T2* MRI technique for detecting iron-dependent blood products [11] . SWI has been used in the evaluation of trauma, tumors, vascular malformations and neurodegenerative diseases [12] . We report a case of dementia with a clinical diagnosis of AD and compare conventional GE-T2* MRI with SWI MRI. In this case, the SWI demonstrated more extensive microhemorrhage involvement of the brain than GE-T2* imaging.
Case Report
on her daughter and granddaughter to answer questions. The neurological examination included normal funduscopic and cranial nerve function, motor, sensory, cerebellar function as well as deep tendon reflex and plantar responses. A detailed neuropsychological evaluation and Clinical Dementia Rating (CDR) was attempted. The Sum of Boxes score on the CDR was 16.0 with a global CDR of 3.0, consistent with severe dementia. Laboratory tests to include serum electrolytes, renal, thyroid liver function, and serum B12 level were within normal limits.
The patient did not have prior brain imaging. Conventional T1, T2, and FLAIR MRI at 1.5T revealed two to three microhemorrhages in the cerebellum. Conventional GE-T2* images also showed several superficial areas of hypointensity (Fig. 1a) . SWI images revealed significantly more numerous microhemorrhages involving both cerebral hemispheres, notably in the occipital lobes, as well as cerebellum (Fig. 1b) .
This patient is still alive so there is no brain specimen available for pathological correlation. An 88-year-old woman with a history of diabetes mellitus type II, medically controlled mild hypertension, asthma/chronic obstructive pulmonary disease, interstitial lung disease, and osteopenia presented to our gerontology service with a two-year history of slow but progressive cognitive impairment. Available history was obtained from the patient's daughter and granddaughter. The patient was living with her daughter and interacting on a daily basis with her family. Nothing in the neurological history suggested a neurovascular disorder -but rather a slow but progressive dementing process. There was no history of sudden or progressive motor or sensory defects, seizure disorders or headaches. Specifically, there was no history of unilateral extremity or facial weakness, diplopia, dysarthria, aphasia or sudden stepwise deterioration in cognitive function. There was no family history of dementia in her parents or siblings despite long life spans. There was no history of concussion or head trauma.
On physical examination, the patient was alert and conversant but with obvious signs of cognitive loss. She relied GE-T2* MR brain imaging is currently the "standard" for identifying microhemorrhages and diagnosing "possible" or "probable" cerebral amyloid angiopathy in life, based on number and distribution of microhemorrhages [6, 8] . SWI MR brain imaging may be superior to GE-T2* for the detection of brain microhemorrhages. We report the first use of SWI to evaluate a patient with a clinical diagnosis of Alzheimer's disease.
SWI MR brain imaging may have significant clinical application. The differential diagnosis of microhemorrhages would include hypertension, trauma and cavernomas. Although there is no pathologic specimen for correlation, the appearance and distribution of the microhemorrhages are most consistent with cerebral amyloid angiopathy. Cerebral amyloid angiopathy with microhemorrhages is known to be prevalent in patients with Alzheimer's disease [10] , but may be unrecognized on clinical evaluation and standard brain imaging. The demonstration of more numerous microhemorrhages on SWI, as compared to GE-T2*, may represent a more sensitive method for detecting cerebral amyloid angiopathy as a contributing factor to the patient's dementia. The early detection of cerebral amyloid angiopathy associated microhemorrhages in patients with Alzheimer's type dementia has significant clinical utility in that the presence of brain microhemorrhages are a risk factor for further significant intracranial hemorrhages. Identification of microhemorrhages may result in clinical recommendations to avoid anticoagulants and anti-platelet therapies in addition to substances with anticoagulant potential [14] [15] .
Systematic and sequential studies using SWI to evaluate mild cognitive impairment and dementia may help elucidate the apparent relationship of cerebral amyloid angiopathy and microhemorrhages to Alzheimer's disease.
In conclusion, SWI brain MRI is a new, sensitive technology for the detection of cerebral microhemorrhages. This case report illustrates the potential of SWI for increased sensitivity in diagnosing microhemorrhages than previously available. SWI may have significant utility in the clinical management of patients with dementia and Alzheimer's disease as well as significant research applications to define the role of cerebral amyloid angiopathy and microhemorrhages in the pathophysiology of dementia.
